0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION
Google image searchProduct monograph
Active ingredients
lidocaine hydrochloride, 4 MG/ML
dextrose, 50 MG/ML
DIN: 00828602
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: CHLORHYDRATE DE LIDOCAÏNE À 0,4 % DANS DU DEXTROSE À 5 % INJECTABLE
Schedule: Ethical
Company: BAXTER CORPORATION
Date: 20-DEC-2019
ATC:
- C01 — CARDIAC THERAPY (ATC, ATC/DDD, )
- C01B — ANTIARRHYTHMICS, CLASS I AND III (ATC, ATC/DDD)
- C01BB — Antiarrhythmics, class Ib (ATC, ATC/DDD)
- C01BB01 — LIDOCAINE (ATC/DDD)
Reference brand drug: Xylocard
Pharmaceutical standard: USP
